Barclays PLC Co Diagnostics, Inc. Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.12 - $10.37 $45,260 - $57,802	-5,574 Reduced 46.23%	6,484 $58,000
Q3 2021 Nov 09, 2021	SELL	$7.48 - $11.38 $178,076 - $270,923	-23,807 Reduced 66.38%	12,058 $117,000
Q2 2021 Aug 13, 2021	SELL	$7.16 - $9.56 $55,540 - $74,156	-7,757 Reduced 17.78%	35,865 $296,000
Q1 2021 May 13, 2021	SELL	$8.52 - $19.21 $808,096 - $1.82 Million	-94,847 Reduced 68.5%	43,622 $416,000
Q4 2020 Feb 11, 2021	SELL	$9.3 - $15.19 $33,349 - $54,471	-3,586 Reduced 2.52%	138,469 $1.29 Million
Q3 2020 Nov 12, 2020	SELL	$8.24 - $30.8 $17,435 - $65,172	-2,116 Reduced 1.47%	142,055 $1.93 Million
Q2 2020 Aug 12, 2020	BUY	$7.46 - $23.42 $1.08 Million - $3.38 Million	144,171 New	144,171 $2.79 Million
Q1 2020 May 13, 2020	SELL	$0.91 - $17.81 $78,960 - $1.55 Million	-86,770 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$0.88 - $1.12 $12,161 - $15,478	13,820 Added 18.94%	86,770 $78,000
Q3 2019 Nov 14, 2019	BUY	$0.81 - $1.35 $44,104 - $73,507	54,450 Added 294.32%	72,950 $75,000
Q2 2019 Aug 14, 2019	BUY	$0.71 - $1.17 $13,135 - $21,645	18,500 New	18,500 $15,000

4.29M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $25M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.